Status:
COMPLETED
A Novel Approach to Optimize Programmed Intermittent Epidural Bolus (PIEB) Delivery for Labour Analgesia
Lead Sponsor:
IWK Health Centre
Conditions:
Labor Pain
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Programmed intermittent epidural bolus (PIEB) for labour analgesia allows an epidural pump to be programmed to deliver small amounts of the local anesthetic and opioid solution at regularly timed inte...
Eligibility Criteria
Inclusion
- Nulliparous,
- English speaking
- 18-45 years
- single gestation ≥ 37 weeks
- vertex presentation
- American Society of Anesthesiologists (ASA) Physical Status II (mild and controlled systemic disease and/or pregnancy)
- requesting an epidural for labour analgesia
- cervical dilation ≤ 7 cm at the time of initiation of epidural analgesia.
Exclusion
- Preeclampsia or HELLP syndrome
- maternal cardiac disease
- severe or uncontrolled maternal systemic disease
- contraindication to neuraxial analgesia (i.e. coagulopathy, infection, neuropathy)
- abnormal spinal anatomy (i.e. severe scoliosis, spina bifida, spinal instrumentation)
- chronic analgesic use
- a physical or psychiatric condition which may impair cooperation
- known fetal anomalies/intrauterine fetal demise
- height \< 5'0"
- Body Mass Index \> 45 kg/m2
Key Trial Info
Start Date :
April 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT03871530
Start Date
April 29 2019
End Date
June 30 2022
Last Update
September 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IWK Health Centre
Halifax, Nova Scotia, Canada, B3K 6R8